HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

glutamyl- (2- (((3,4- dihydro- 2,5,7,8- tetramethyl- 2- (4,8,12- trimethyltridecyl)- 2H- 1- benzopyran- 6- yl)oxy)carbonyl)- 3- ((2- (1H- indol- 3- yl)ethyl)amino)- 3- oxopropyl)- cysteinyl- glycine sodium salt

structure in first source
Also Known As:
ESeroS-GS; gamma-L-glutamyl-S-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxopropyl)-L-cysteinyl-glycine sodium salt
Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Zhao, Lijing: 2 articles (12/2014 - 05/2011)
2. Zhao, Kai: 2 articles (12/2014 - 05/2011)
3. Ogata, Kazumi: 2 articles (12/2014 - 05/2011)
4. Wei, Taotao: 2 articles (12/2014 - 05/2011)
5. Mori, Akitane: 2 articles (12/2014 - 05/2011)
6. Zhang, Bo: 1 article (12/2014)
7. Zhao, Xingyu: 1 article (12/2014)
8. Zhang, Fenglin: 1 article (12/2014)
9. Fang, Yi: 1 article (12/2014)
10. Wei, Peng: 1 article (12/2014)

Related Diseases

1. Ischemia
2. Breast Neoplasms (Breast Cancer)
3. Sepsis (Septicemia)
4. Reperfusion Injury
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Vitamin E
2. Reactive Oxygen Species (Oxygen Radicals)
3. Sodium
4. cysteinylglycine (Cys-Gly)